The enduring success of sildenafil has undeniably shaped the healthcare landscape. However, investing in companies heavily dependent on biosimilars and the waning patent rights surrounding this flagship https://socialinplace.com/story6873407/sildenafil-and-pharmaceutical-companies-a-risky-venture